| Literature DB >> 30090843 |
James Robert Brašić1, Zoltan Mari2, Alicja Lerner3, Vanessa Raymont1, Eram Zaidi1, Dean F Wong1.
Abstract
Heat has been reported to exert variable effects on people with Gilles de la Tourette syndrome (TS). At age 24 years, a 32-year-old right-handed man with TS experienced a marked reduction in tics for two years after undergoing dehydration by entering a hot tub at 103°F (39.4°C) to 104°F (40.0°C) for 3 to 4 hours. On the Yale Global Tic Severity Scale (YGTSS) he scored 55 seven months before dehydration and 13 one month after dehydration. An intense heat exposure and dehydration led to an apparent remission in tics. The remission continued without the use of prescribed or nonprescribed medications or substances for two years until tics returned in the worst ever exacerbation after a tetanus immunization. The heat exposure may have altered at least temporarily his thermostat for normal heat-loss mechanisms through dopaminergic pathways from the anterior hypothalamus to the basal ganglia and the substantia nigra. Whether or not that mechanism or some other mechanism relevant to the heat exposure and/or dehydration is at play, the sudden and marked improvement in his tics needs further attention. Prospective testing of the heat and dehydration effect on tics should be pursued.Entities:
Keywords: Basal ganglia; Dopamine; Hypothalamus; Substantia nigra; Thermoregulation; Thermostat; Tics
Year: 2018 PMID: 30090843 PMCID: PMC6078428 DOI: 10.4172/2329-9096.1000472
Source DB: PubMed Journal: Int J Phys Med Rehabil ISSN: 2329-9096
Objective assessments of a 25-year-old man 7 months before and 1 and 11 months after an almost full remission following dehydration in a hot tub at 103°F (39.4°C) to 104°F (40.0°C) for 3 to 4 hours.
| Instrument | Range of scores | Six months before remission | One month after remission | Eleven months after remission |
|---|---|---|---|---|
| Urine drug toxicology for tetrahydrocannabis | Negative or positive | Negative | Positive | Positive |
| Abnormal Involuntary Movement Scale (AIMS)
[ | (0,40) | 9 | 0 | 1 |
| Clinical Global Impression (CGI) Severity
Index (SI) [ | (0,7) | 4 Moderately mentally ill | 3 Mildly ill | 2 Borderline mentally ill |
| Clinical Global Impression (CGI) Global
Improvement (GI) [ | (0,7) | 4 No change | 2 Much improved | 1 Very much improved |
| Clinical Global Impression (CGI) Efficacy
Index (EI) [ | (0,16) | 13 | 5 | 13 |
| Clinical Global Impression (CGI) Therapeutic
effect [ | Not applicable | Unchanged or worse | Moderate | Unchanged or worse |
| Clinical Global Impression (CGI) Side effects
[ | Not applicable | None | None | None |
| Clinical Global Impression (CGI) Attention
Deficit Disorder (ADD) [ | (0,6) | 1 Borderline | 0 | 1 Borderline |
| Clinical Global Impression (CGI)
Obsessive-Compulsive Disorder (OCD) [ | (0,6) | 3 Moderate | 2 | 2 Mild |
| Clinical Global Impression (CGI) Tourette
syndrome (TS) [ | (0,6) | 3 Moderate | 1 | 1 Borderline |
| Clinical Global Improvement (CGI) Rater Global
Evaluation (RGE) [ | (1,7) | 4 Unchanged | 2 Much improved | 1 Very much improved |
| Hillside Akathisia Scale (HAS) Subjective
items [ | (0,8) | 0 | 0 | 0 |
| Hillside Akathisia Scale (HAS) Objective items
[ | (0,12) | 6 | 0 | 0 |
| Hillside Akathisia Scale (HAS) Clinical Global
Impression (CGI) Severity of Akathisia (SA) [ | (0,7) | 3 Mildly akathisic | 1 Normal, not akathisic | 1 Normal, not akathisic |
| Hillside Akathisia Scale (HAS) Clinical Global
Impression (CGI) Global Improvement (GI) [ | (0,7) | 4 No change | 1 Very much improved | 1 Very much improved |
| Magnetic resonance imaging of the brain [ | Normal or abnormal | Normal | Normal | Normal |
| Maryland Psychiatric Research Center (MPRC)
Brief Psychiatric Rating Scale (BPRS) Anchors [ | (20,140) | 26 | 21 | 21 |
| Movement Disorders Checklist [ | (0,23) | 14 | 8 | 0 |
| Myoclonus versus tic checklist [ | (−2,6) | 6 | 3 | 0 |
| National Institutes of Mental Health (NIMH)
Obsessive-Compulsive Scale (OCS) [ | (0,15) | 5 | 2 | 1 |
| Rating Scale for Acute Drug-Induced Akathisia
(RSADIA) Subjective [ | (0,9) | 0 | 0 | 0 |
| Rating Scale for Acute Drug-Induced Akathisia
(RSADIA) Objective [ | (0,21) | 1 | 0 | 0 |
| Rating Scale for Acute Drug-Induced Akathisia
(RSADIA) Global Rating [ | (0,3) | 0 | 0 | 0 |
| Rating scale for drug-induced akathisia
(RSDIA) Subjective [ | (0,6) | 0 | 0 | 0 |
| Rating scale for drug-induced akathisia
(RSDIA) Objective [ | (0,3) | 1 | 0 | 0 |
| Rating scale for drug-induced akathisia
(RSDIA) Global Clinical Assessment of Akathisia (GCAA) [ | (0,5) | 1 | 0 | 0 |
| Rating Scale for Tardive Dyskinesia (RSTD)
Face [ | (16,96) | 26 | 17 | 18 |
| Rating Scale for Tardive Dyskinesia (RSTD)
Neck and trunk [ | (8,48) | 11 | 8 | 8 |
| Rating Scale for Tardive Dyskinesia (RSTD)
Extremities (upper) [ | (8,48) | 11 | 8 | 8 |
| Rating Scale for Tardive Dyskinesia (RSTD)
Extremities (lower) [ | (8,48) | 8 | 8 | 8 |
| Rating Scale for Tardive Dyskinesia (RSTD)
Entire body [ | (4,24) | 4 | 4 | 4 |
| Timed Stereotypies Rating Scale [ | (0,1000) | 27 | 2 | 1 |
| Tourette Syndrome Diagnostic Confidence Index
(TSDCI) [ | (0,100) | 61 | Missing | 82 |
| Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
[ | (0,40) | 4 | 10 | 4 |
| Obsessive-Compulsive Disorder through the
application of the criteria current at the time of the study [ | (0,1) | 0 | 1 | 0 |
| Yale Global Tic Severity Scale (YGTSS) Motor
[ | (0,25) | 19 | 13 | 12 |
| Yale Global Tic Severity Scale (YGTSS) Phonic
[ | (0,25) | 9 | 0 | 11 |
| Yale Global Tic Severity Scale (YGTSS)
Impairment [ | (0,50) | 27 | 0 | 9 |
Obsessive-Compulsive Disorder (OCD) is diagnosed [32] if on the Y-BOCS [30,31] a person scores 2, 3, or 4 on any of the following items: 1 time spent on obsessions, or 2 interference from obsessions, or 3 distress of obsessions, or 6 time spent on compulsions, or 7 interference from compulsions, or 8 distress of compulsions